SCHEMBL13304698

SCHEMBL13304698

Cc1cnn2c(Cl)cc(-c3ccc(Cl)cc3Cl)nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.50
HSP90AB1 P08238 2/20 0.50
HSD11B1 P28845 2/20 0.42
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.41
RAB9A P51151 4/20 0.41
CRHR1 P34998 4/20 0.41
DPP4 P27487 2/20 0.41
LMNA P02545 1/20 0.40
GSK3B P49841 1/20 0.38
HPGD P15428 3/20 0.38
NPC1 O15118 3/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953050 0.83 GSK3B (0.52) HSP90AA1HSP90AB1HSD11B1KDM4EMAPT
SCHEMBL13305024 0.83 HSP90AA1 (0.41) HSP90AA1HSP90AB1HSD11B1KDM4EALDH1A1
SCHEMBL13304770 0.77 CDK2 (0.47) HSD11B1KDM4EALDH1A1MAPTRAB9A
SCHEMBL13304790 0.75 MAPT (0.57) KDM4EALDH1A1MAPTRAB9AHPGD
SCHEMBL13650606 0.75 ALDH1A1 (0.44) KDM4EALDH1A1MAPTRAB9AHPGD
SCHEMBL12953049 0.72 PDE10A (0.58) HSP90AA1HSP90AB1HSD11B1KDM4EALDH1A1
SCHEMBL19455177 0.72 MAPT (0.59) KDM4EALDH1A1MAPTRAB9ALMNA
SCHEMBL13304823 0.71 MAPT (0.41) KDM4EALDH1A1MAPTRAB9ALMNA
SCHEMBL13304775 0.69 KDM4E (0.49) KDM4EALDH1A1MAPTRAB9ALMNA
SCHEMBL21754311 0.69 KDM4E (0.42) KDM4EALDH1A1MAPTRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 EP disclosed